Interventional oncology for hepatocellular carcinoma

Area of Science:

• Hepatology
• Oncology
• Interventional Radiology

Background:

• Hepatocellular carcinoma (HCC) is the most common primary liver cancer with increasing incidence and poor patient prognosis.
• The Barcelona Clinic Liver Cancer (BCLC) staging system guides treatment allocation for HCC.
• Curative surgical options are limited, necessitating effective locoregional therapies.

Purpose of the Study:

• To review available interventional oncology (IO) treatments for HCC.
• To assess the evidence supporting various IO techniques in HCC management.

Main Methods:

• Review of existing literature on interventional oncology (IO) techniques for HCC.
• Focus on image-guided therapies including percutaneous and endovascular approaches.

Main Results:

• Locoregional therapies are crucial for managing HCC when curative surgery is not an option.
• Image-guided IO techniques offer percutaneous or endovascular treatment modalities for HCC.

Conclusions:

• Interventional oncology (IO) provides essential treatment options for Hepatocellular carcinoma (HCC) patients.
• Further evaluation of the strength of evidence for different IO treatments is warranted.